Emergent BioSolutions Inc. (LON:0IGA)
9.90
+0.26 (2.70%)
At close: Oct 24, 2025
Emergent BioSolutions Employees
Emergent BioSolutions had 900 employees as of December 31, 2024. The number of employees decreased by 700 or -43.75% compared to the previous year.
Employees
900
Change (1Y)
-700
Growth (1Y)
-43.75%
Revenue / Employee
690.65K GBP
Profits / Employee
113.13K GBP
Market Cap
380.36M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 900 | -700 | -43.75% |
| Dec 31, 2023 | 1,600 | -900 | -36.00% |
| Dec 31, 2022 | 2,500 | 84 | 3.48% |
| Dec 31, 2021 | 2,416 | 216 | 9.82% |
| Dec 31, 2020 | 2,200 | 366 | 19.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Spire Healthcare Group | 15,703 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
Emergent BioSolutions News
- 11 days ago - Emergent BioSolutions EVP Sold $306K In Company Stock - Benzinga
- 21 days ago - Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025 - GlobeNewsWire
- 4 weeks ago - Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone - GlobeNewsWire
- 5 weeks ago - Emergent BioSolutions (EBS) Lands $29M International Supply Agreement - GuruFocus
- 5 weeks ago - Emergent BioSolutions (EBS) Lands $29 Million Government Contract - GuruFocus
- 5 weeks ago - Emergent Biosolutions secures $29M in MCM product orders from international government partner - Seeking Alpha
- 5 weeks ago - Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner - GlobeNewsWire
- 6 weeks ago - Emergent BioSolutions Wins $17 Million BARDA Contract To Supply Tembexa Oral Suspension - Nasdaq